Jiazhen Xu

Introduction There are no effective therapeutics for several fatal neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD).

Abstract The rising global burden of cerebrovascular disease, propelled by an aging population, highlights the inherent limitations of conventional, labor-intensive diagnostic paradigms. In the context of time-sensitive stroke management, variability in image interpretation and the high rate of misclassification, particularly during the assessment of transient ischemic attack (TIA), underscore the urgent need for more consistent and efficient diagnostic solutions.